Withdrawn × Lymphoma × Plasma cell × Clear all
NCT00085449 2019-11-27

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Alliance for Clinical Trials in Oncology

Phase 1/2 Withdrawn
NCT00770419 2015-05-29

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Rutgers, The State University of New Jersey

Withdrawn
NCT00898612 2014-03-10

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Mayo Clinic

Withdrawn
NCT01101412 2013-02-15

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
NCT00301912 2012-10-02

Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

University of California, San Francisco

Phase 2 Withdrawn